L-1A Sustained — Biopharmaceutical Research (2020): the Director denied the petition, citing inconsistencies

Decision Summary

The Director denied the petition, citing inconsistencies from a consular interview and insufficient evidence of the beneficiary's managerial or executive capacity. On appeal, the AAO found that the petitioner had provided sufficient supporting evidence (including job descriptions, FDA approvals, and investment information) to meet the preponderance of the evidence standard, and therefore sustained the appeal.

Criteria Discussed

Sign up free to download the original PDF